Purchase Order HHSD2002016M90630P
- Not listed
- This federal contract award is for the purchase of laboratory equipment from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $140,700.00, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various...
- This federal contract award to Illumina, Inc. is for the procurement of a MiSeq System, a genetic sequencing platform and associated consumables and services. The $93,529 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract does not have a set-aside designation. Illumina is a leading manufacturer of advanced genetic sequencing instruments, reagents, and bioinformatics software. The company has been awarded multiple federal...
- This $96,401.25 firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract is for the provision of a MiSeq DNA sequencing system and does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the NIH, USDA, VA, and others for sequencing systems, reagents, and...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and software. The contract is for the purchase of a MiSeq System, a benchtop DNA sequencing platform, for $95,931. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received other federal prime and subcontract awards from agencies like the National Institutes of Health (NIH),...
- This firm fixed-price federal contract award to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis equipment, was made by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. The $233,603.32 contract is for the provision of NEXTSEQ 1000 LEDERMANN sequencing systems and associated products and services. The contract has a period of performance through September 30, 2024. This award does not have a set-aside designation. Illumina has been awarded...
- This firm fixed-price federal contract award to Illumina, Inc. is for the provision of laboratory equipment, valued at $205,800.00. The contract was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh and has a ceiling value of $205,800.00. The contract does not have a set-aside designation. Based on Illumina's background as a manufacturer and provider of sequencing and genomic analysis solutions, the equipment being provided likely includes various NextSeq, NovaSeq, MiSeq,...
- This is a firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract, valued at $80,865.64, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to support the CDC's genomic research and analysis needs. This order is placed under the broader ILLUMINA BOA contract vehicle, which is an...
- This federal contract award to Illumina, Inc. is for the purchase of a NEXTSEQ 1000 SEQ SYSTEM, a genetic sequencing instrument, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The $159,600.00 firm fixed-price purchase order does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has received previous prime contract awards from federal agencies like the NIH, USDA, and VA to support...
- This firm fixed-price contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The $158,939.56 award is for the provision of Illumina's MiSeq sequencing platform and related consumables to support comprehensive genomic analysis work. This contract is not set aside for any small business categories. Illumina has previously received prime contract awards from...
- This federal contract award, valued at $99,813.12, was issued by the National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The award is for the delivery of Illumina's sequencing systems, including the NextSeq, NovaSeq, MiSeq, and iSeq platforms, along with accompanying reagents, consumables, and support services. This contract is not subject to any set-aside requirements. Illumina has previously received...
This federal contract award, valued at $142,053.98, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a manufacturer of genomic sequencing equipment and reagents. The contract is for the provision of laboratory equipment, specifically various Illumina sequencing systems including NextSeq, NovaSeq, MiSeq, and iSeq, as well as associated consumables, sample preparation kits, and bioinformatics products. Illumina has previously been awarded other federal contracts and subcontracts by agencies such as the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to support genomic research and diagnostics. This contract does not have a set-aside designation and is a firm fixed-price purchase order. Illumina holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery for nucleic acid sequencing, and has also received a federal sub-grant from the New Hampshire Department of Health and Human Services for MiSeq instrument maintenance services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $142.1k | 7/7/16 |